EligibleTrials

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Recruiting · NCT05746182 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of California, San Francisco

View the official record on ClinicalTrials.gov →
Pancreatic cancer

Interventions studied

Hereditary Cancer Panel

What this trial is about

This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

3 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.